0001209191-15-028043.txt : 20150319 0001209191-15-028043.hdr.sgml : 20150319 20150319195612 ACCESSION NUMBER: 0001209191-15-028043 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150319 FILED AS OF DATE: 20150319 DATE AS OF CHANGE: 20150319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SteadyMed Ltd. CENTRAL INDEX KEY: 0001619087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 BUSINESS PHONE: 972-3-6449556 MAIL ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIGBY JONATHAN CENTRAL INDEX KEY: 0001356227 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36889 FILM NUMBER: 15714226 MAIL ADDRESS: STREET 1: ARADIGM CORPORATION STREET 2: 3929 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-03-19 0 0001619087 SteadyMed Ltd. STDY 0001356227 RIGBY JONATHAN C/O STEADYMED THERAPEUTICS, INC 2410 CAMINO RAMON SAN RAMON CA 94583 1 1 0 0 See Remarks Stock Option (Rt to Buy) 3.61 2018-08-11 Ordinary Shares 88831 D Stock Option (Rt to Buy) 3.61 2019-07-19 Ordinary Shares 152342 D Stock Option (Rt to Buy) 3.61 2020-05-01 Ordinary Shares 18515 D Stock Option (Rt to Buy) 3.61 2021-07-07 Ordinary Shares 108702 D Stock Option (Rt to Buy) 3.61 2021-07-07 Ordinary Shares 36510 D Stock Option (Rt to Buy) 5.84 2022-01-25 Ordinary Shares 131541 D Stock Option (Rt to Buy) 3.61 2020-02-14 Ordinary Shares 3875 I By Spouse Stock Option (Rt to Buy) 5.84 2022-01-25 Ordinary Shares 3875 I By Spouse Fully vested. 1/3rd of the Option Shares shall vest on July 19, 2013. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on October 19, 2013 until fully vested. 1/3rd of the Option Shares shall vest on May 1, 2014. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on September 30, 2014 until fully vested. 1/3rd of the Option Shares shall vest on February 24, 2015. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on June 30, 2015 until fully vested. 1/3rd of the Option Shares shall vest on February 24, 2015. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on June 30, 2015 until fully vested. 1/3rd of the of the Option Shares shall vest on January 28, 2016. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on March 1, 2016 until fully vested. 1/3rd of the Option Shares shall vest on February 14, 2013. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on May 14, 2013 until fully vested. 1/3rd of the Option Shares shall vest on January 28, 2016. Thereafter, the balance of the Option Shares shall vest in a series of eight equal consecutive quarterly installments commencing on March 1, 2016 until fully vested. President and Chief Executive Officer /s/ Michael E. Tenta, Attorney-In-Fact 2015-03-19 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and
appoints each of David W. Nassif and Michael E. Tenta, signing individually, the
undersigned's true and lawful attorneys-in fact and agents to:

                (1) execute for and on behalf of the undersigned, in the
        undersigned's capacity as an officer, director or beneficial owner of
        more than 10% of a registered class of securities of SteadyMed Ltd. (the
        "Company"), Forms 3, 4 and 5 (including any amendments thereto) in
        accordance with Section 16(a) of the Securities Exchange Act of 1934, as
        amended (the "Exchange Act") and the rules thereunder and a Form ID,
        Uniform Application for Access Codes to File on EDGAR;

                (2) do and perform any and all acts for and on behalf of the
        undersigned that may be necessary or desirable to execute such Forms 3,
        4 or 5 or Form ID (including any amendments thereto) and timely file
        such forms with the United States Securities and Exchange Commission and
        any stock exchange or similar authority; and

                (3) take any other action of any nature whatsoever in connection
        with the foregoing which, in the opinion of such attorney-in-fact, may
        be of benefit, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such
        attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by the Company or Cooley LLP.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of March 19, 2015.

                                        /s/ Jonathan M. N. Rigby
                                        ----------------------------------------
                                        JONATHAN M.N. RIGBY